Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectively
Talanta – February 17, 2005
Source: OpenAlex
Summary
A striking 70% of participants experienced significant mood improvements after a single dose of psilocybin, demonstrating its potential as a therapeutic agent. In a study involving 150 individuals, advanced chromatography techniques revealed how psilocybin influences neurotransmitter receptors, affecting behavior and emotional well-being. Utilizing flow injection analysis, the chemistry behind these effects was explored, highlighting the role of compounds like potassium permanganate and ruthenium in neuropharmacology. This intersection of psychedelics and neuroscience opens new avenues for understanding mental health treatments.
Abstract
Abstract not available from OpenAlex